A Phase 2 interventional study of s.c. human chorionic gonadotropin (Ovitrelle) in Fertility Agents, Female, sponsored by Hadassah Medical Organization. Completed at 1 site in Israel. Open to female participants aged 18 Years to 45 Years. Per ClinicalTrials.gov, last updated 2009-01-01.
Sponsored by Hadassah Medical Organization · Phase 2, Interventional, and Treatment
The implantation rate after frozen-thawed embryo transfer cycles depends mostly on the receptivity of the endometrium and the embryo quality.The effects of human chorionic gonadotropins (hCG) on the endometrium have been investigated for several years. hCG was shown to up-regulate gene expression during the differentiation of human endometrial stromal cells into decidua. The aim of our study was to assess the benefit of hCG supplementation throughout the secretory phase of artificial frozen-thawed embryo transfer cycles.
Hadassah Medical Organization is the lead sponsor of 660 studies on the registry; 54 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Exclusion Criteria:
receiving hCG injection
Drug: s.c. human chorionic gonadotropin (Ovitrelle)
Drug: s.c. human chorionic gonadotropin (Ovitrelle)
S.C. Ovitrelle 250 mcg once
implantation rate
Time frame: 4 weeks
pregnancy rate
Time frame: 4 weeks
This study is completed, as verified in Nov 2007. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Hadassah Medical Organization